Associations [menp]
P2Y12 [gngm]
Receptor Gene [gngm]
polymorphisms [genf]
Susceptibility [clna]
coronary heart disease [dsyn]
Efficacy [qlco]
treatment [ftcn]
clopidogrel [orch, phsu]
Objective [inpr]
investigate [ftcn]
Correlation [qlco]
P2Y12 [gngm]
Receptor Gene [gngm]
polymorphisms [genf]
Susceptibility [clna]
coronary artery disease [dsyn]
CHD [topp]
Efficacy [qlco]
clopidogrel [orch, phsu]
treatment [ftcn]
CHD [topp]
Methods [inpr]
CHD [topp]
Patients [podg]
Group [idcn]
Healthy Control [qlco]
Control Group [grup]
Select [acty]
Hospital [hcro, mnob]
Platelet rich plasma [bdsu]
PRP [dsyn]
Turbidimetry [lbpr]
Measure [qnco]
Adenosine Diphosphate [bacs, nnon]
Induced platelet aggregation [celf]
clopidogrel [orch, phsu]
treatment [ftcn]
clopidogrel [orch, phsu]
Sensitive [ftcn]
Group [idcn]
Defined [cnce]
A-10 [orch, phsu]
Decrease [qlco]
Platelet aggregation [celf]
10 days [tmco]
clopidogrel [orch, phsu]
treatment [ftcn]
clopidogrel [orch, phsu]
Resistant [ftcn]
Group [idcn]
Defined [cnce]
A-10 [orch, phsu]
Decrease [qlco]
Genotyping [lbpr]
Performed [ftcn]
Chromatography, High Performance Liquid [lbpr]
Haplotype [orga]
P2Y12 [gngm]
Receptor Gene [gngm]
polymorphisms [genf]
Performed [ftcn]
Software [inpr, mnob]
Genotype [orga]
Frequencies, Allele [qnco]
Control Groups [grup]
P NOS [aapp, imft]
Haplotypes [orga]
GTA [gngm]
TTA [fndg]
chd risk [fndg]
P NOS [aapp, imft]
Haplotype [orga]
TCA [geoa]
chd risk [fndg]
P NOS [aapp, imft]
CHD [topp]
Patients [podg]
clopidogrel [orch, phsu]
Sensitive [ftcn]
Group [idcn]
High frequency [tmco]
TT [geoa]
Genotype [orga]
Frequencies [tmco]
GG [geoa]
Genotype [orga]
clopidogrel [orch, phsu]
Resistant [ftcn]
Group [idcn]
P NOS [aapp, imft]
Conclusions [idcn]
P2Y12 [gngm]
Receptor Gene [gngm]
polymorphisms [genf]
CHD [topp]
Efficacy [qlco]
clopidogrel [orch, phsu]
treatment [ftcn]
CHD [topp]
